| | Identification | Back Directory |  | [Name] 
 Farletuzumab
 |  | [CAS] 
 896723-44-7
 |  | [Synonyms] 
 Farletuzuma
 Farletuzumab
 Farletuzumab (anti-FOLR1)
 Research Grade Farletuzumab(DHD10401)
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer[1].
 |  | [References] 
 [1] Ebel W, et, al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007 Mar 9;7:6. PMID:17346028
 | 
 | 
                    
                        
                            | Company Name: | Biolab Reagents |  
                            | Tel: | 027-65279366 18108604356 |  
                            | Website: | www.biolabreagent.com/ |  |